Ignite Creation Date:
2024-05-06 @ 2:45 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04412746
Status:
UNKNOWN
Last Update Posted:
2020-06-02
First Post:
2020-06-01
Brief Title:
Covid-19 and Diabetes in West of Algeria
Sponsor:
Laboratoire De Recherche Sur Le Diabete Université de Tlemcen
Organization:
Laboratoire De Recherche Sur Le Diabete Université de Tlemcen
Study Overview
Official Title:
Prevalence of Diabetes Among Hospitalized Patients With Covid-19 in West of Algeria Identification of Diabetes-related Associated Factors Severe Forms
Status:
UNKNOWN
Status Verified Date:
2020-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COVIDIAB-13
Brief Summary:
By Jan 7 2020 Chinese scientists had isolated a novel coronavirus from patients with virus-infected pneumonia The WHO designated later this virus as COVID-19 coronavirus disease 2019 This exponential pandemic coronavirus infection is responsible for severe forms in 15 to 20 for critical ill requiring ventilation in 5 and for mortality in 2 Algeria was part of the 13 top priority countries identified by WHO based on their direct links and volume of travel to the infected provinces in China
It is known that some predisposing conditions lead to a worse outcome with coronavirus
In China the overall case-fatality rate was 23 but was higher in patients with diabetes 73 In Italy the most common comorbidities associated with death from COVID-19 were hypertension 738 and diabetes 339 The US Centers for Disease Control and Prevention suggests diabetes is the most common comorbidity in COVID-19 cases In the largest cohort NHS England study death from COVID-19 was strongly associated with uncontrolled diabetes after full adjustment HR 236
The West Algerian CORODIAB-13 study aims is 1 to assess the prevalence of diabetes among hospitalized patients with Covid-19 2 to describe the phenotypic characteristics of patients with diabetes and 3 to identify the parameters specific to the diabetic which are associated with severe forms
In the future this study will provide answers for two main questions
1 Why diabetics are more at risk of developing Covid-19 infection
2 Why diabetics are at high risk of developing severe forms
It is known that some predisposing conditions lead to a worse outcome with coronavirus
In China the overall case-fatality rate was 23 but was higher in patients with diabetes 73 In Italy the most common comorbidities associated with death from COVID-19 were hypertension 738 and diabetes 339 The US Centers for Disease Control and Prevention suggests diabetes is the most common comorbidity in COVID-19 cases In the largest cohort NHS England study death from COVID-19 was strongly associated with uncontrolled diabetes after full adjustment HR 236
The West Algerian CORODIAB-13 study aims is 1 to assess the prevalence of diabetes among hospitalized patients with Covid-19 2 to describe the phenotypic characteristics of patients with diabetes and 3 to identify the parameters specific to the diabetic which are associated with severe forms
In the future this study will provide answers for two main questions
1 Why diabetics are more at risk of developing Covid-19 infection
2 Why diabetics are at high risk of developing severe forms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None